Mark Dybul

1.3k total citations
12 papers, 649 citations indexed

About

Mark Dybul is a scholar working on Infectious Diseases, Virology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark Dybul has authored 12 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark Dybul's work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). Mark Dybul is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). Mark Dybul collaborates with scholars based in United States, United Kingdom and Switzerland. Mark Dybul's co-authors include Anthony S. Fauci, A. Rubbert, Sundararajan Venkatesan, Joshua Μ. Farber, James Arthos, Ruth Swofford, Drew Weissman, Ronald L. Rabin, Michel D. Kazatchkine and Peter Piot and has published in prestigious journals such as Nature, The Lancet and Journal of Virology.

In The Last Decade

Mark Dybul

12 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Dybul United States	11	379	250	233	82	78	12	649
Fatim Cham United States	12	361 1.0×	205 0.8×	208 0.9×	99 1.2×	97 1.2×	21	618
Meghan Rothenberger United States	6	455 1.2×	135 0.5×	350 1.5×	100 1.2×	56 0.7×	14	644
Sherry L. Orloff United States	14	547 1.4×	134 0.5×	610 2.6×	279 3.4×	130 1.7×	18	929
Nobubelo Ngandu South Africa	15	315 0.8×	159 0.6×	327 1.4×	185 2.3×	112 1.4×	34	679
Gilles Darcis Belgium	18	655 1.7×	203 0.8×	584 2.5×	220 2.7×	274 3.5×	70	1.1k
Michael Wohlfeiler United States	14	637 1.7×	107 0.4×	758 3.3×	280 3.4×	82 1.1×	31	1.1k
Scott C. Brun United States	15	1.4k 3.7×	158 0.6×	1.5k 6.5×	183 2.2×	84 1.1×	16	1.8k
Emilia Rivadeneira United States	14	200 0.5×	120 0.5×	323 1.4×	150 1.8×	50 0.6×	42	530
Julie Lajoie Canada	19	300 0.8×	505 2.0×	160 0.7×	188 2.3×	85 1.1×	47	969
Zacarias J da Silva Guinea-Bissau	14	349 0.9×	180 0.7×	346 1.5×	141 1.7×	41 0.5×	15	577

Countries citing papers authored by Mark Dybul

Since Specialization

Citations

This map shows the geographic impact of Mark Dybul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dybul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dybul more than expected).

Fields of papers citing papers by Mark Dybul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Dybul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dybul. The network helps show where Mark Dybul may publish in the future.

Co-authorship network of co-authors of Mark Dybul

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Dybul. A scholar is included among the top collaborators of Mark Dybul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Dybul. Mark Dybul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Clark, Helen, Mauricio Cárdenas, Mark Dybul, et al.. (2022). Transforming or tinkering: the world remains unprepared for the next pandemic threat. The Lancet. 399(10340). 1995–1999. 13 indexed citations

Nsanzimana, Sabin, Angeli Rawat, Lindsay A. Wilson, et al.. (2022). Toward a New Paradigm of North–South and South–South Partnerships for Pandemic Preparedness: Lessons Learned from COVID-19 and Other Outbreaks. American Journal of Tropical Medicine and Hygiene. 107(6). 1162–1165. 1 indexed citations

Kazatchkine, Michel D., Joanne Liu, Mark Dybul, et al.. (2021). Vaccines, therapeutics, and diagnostics for covid-19: redesigning systems to improve pandemic response. BMJ. 375. e067488–e067488. 16 indexed citations

Lewin, Sharon R., Brian Doehle, Karine Dubé, et al.. (2020). Multi-stakeholder consensus on a target product profile for an HIV cure. The Lancet HIV. 8(1). e42–e50. 48 indexed citations

Sridhar, Devi, Ngaire Woods, Mark Dybul, et al.. (2018). Global governance of antimicrobial resistance. The Lancet. 391(10134). 1976–1978. 82 indexed citations

Dybul, Mark, Peter Piot, & Julio Frenk. (2012). Reshaping Global Health. LSHTM Research Online (London School of Hygiene and Tropical Medicine). 173(173). 3–18. 13 indexed citations

Piot, Peter, Michel D. Kazatchkine, Mark Dybul, & Julian Lob‐Levyt. (2009). AIDS: lessons learnt and myths dispelled. The Lancet. 374(9685). 260–263. 53 indexed citations

Reynolds, Steven J., Cissy Kityo, Robin Dewar, et al.. (2009). Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda. Antiviral Therapy. 14(2). 293–297. 28 indexed citations

Dybul, Mark, Robin Dewar, Frank Maldarelli, et al.. (2004). A Proof‐of‐Concept Study of Short‐Cycle Intermittent Antiretroviral Therapy with a Once‐Daily Regimen of Didanosine, Lamivudine, and Efavirenz for the Treatment of Chronic HIV Infection. The Journal of Infectious Diseases. 189(11). 1974–1982. 44 indexed citations

10.

Dybul, Mark, Marybeth Daucher, Mark A. Jensen, et al.. (2003). Genetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral Therapy. Journal of Virology. 77(5). 3229–3237. 35 indexed citations

11.

Dybul, Mark, A. Rubbert, Elizabeth S. Machado, et al.. (1998). Short Communication : The Role of Dendritic Cells in the Infection of CD4 ⁺ T Cells with the Human Immunodeficiency Virus: Use of Dendritic Cells from Individuals Homozygous for the Δ 32CCR5 Allele as a Model. AIDS Research and Human Retroviruses. 14(13). 1109–1113. 11 indexed citations

12.

Weissman, Drew, Ronald L. Rabin, James Arthos, et al.. (1997). Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature. 389(6654). 981–985. 305 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact